THE ASSOCIATION OFFERS SERVICES, PROGRAMS AND ACTIVITIES DESIGNED TO SUPPORT THE BUSINESS DEVELOPMENT OBJECTIVES OF ITS MEMBERS.
Executive compensation, broken down
Form 990 · Part VII & Schedule J · 6 reported individuals · Filing year 2023
Percentile bands compare each position's total pay with the same role at nonprofits nationwide, across all sectors.
- Base
- $277k
- Bonus
- $58k
- Other
- —
- Benefits
- $8k
- Base
- $115k
- Bonus
- —
- Other
- $66k
- Benefits
- $10k
| Position | Base | Bonus | Other | Benefits | Total |
|---|---|---|---|---|---|
Advisor to Executive Director Above 90th percentile | $277k | $58k | — | $8k | $360k $402k |
Deputy Director Highest Compensated Employee Median to 75th percentile | $115k | — | $66k | $10k | $191k $213k |
Editorial Director Highest Compensated Employee 25th percentile to median | — | — | — | — | $144k $160k |
Director of Member Services Highest Compensated Employee 25th percentile to median | — | — | — | — | $129k $144k |
Director of Technology Highest Compensated Employee 25th percentile to median | — | — | — | — | $129k $144k |
Executive Director Median to 75th percentile | — | — | — | — | $120k $134k |
Teal figures restate each filed amount in 2026 dollars.
Estimated with BLS CPI-U for the Northeast region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Plus 11 unpaid individuals.
Down 14%
from 2022
From $420k in 2022 to $360k in 2023.
Estimated with BLS CPI-U for the Northeast region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Chief Executive Officer pay fell 14% from 2022 to 2023, while revenue rose 6%.
Pay for the position itself, not any one person. The officeholder may have changed between 2022 and 2023.
Revenue and expenses over time
DRUG CHEMICAL & ASSOCIATED TECHNOLOGIES ASSOCIATION reported revenue and expenses across 2 filing years.
Common questions about DRUG CHEMICAL & ASSOCIATED TECHNOLOGIES ASSOCIATION
What does the Chief Executive Officer of DRUG CHEMICAL & ASSOCIATED TECHNOLOGIES ASSOCIATION earn?
In 2023, the Chief Executive Officer of DRUG CHEMICAL & ASSOCIATED TECHNOLOGIES ASSOCIATION received $360,083 in total compensation. This pay is in the top 10% for Chief Executive Officer roles among nonprofits nationwide, across all sectors: at least 9 in 10 comparable filings report less. Based on IRS Form 990 data.
How does Chief Executive Officer pay at DRUG CHEMICAL & ASSOCIATED TECHNOLOGIES ASSOCIATION compare with similar nonprofits?
Compared with the same role at nonprofits nationwide, across all sectors, the 2023 pay of the Chief Executive Officer at DRUG CHEMICAL & ASSOCIATED TECHNOLOGIES ASSOCIATION falls in the top 10%.
What are DRUG CHEMICAL & ASSOCIATED TECHNOLOGIES ASSOCIATION's revenue and expenses?
In 2023, DRUG CHEMICAL & ASSOCIATED TECHNOLOGIES ASSOCIATION reported $5.9M in total revenue and $4.7M in total expenses on its IRS Form 990.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.
Learn More About Nonprofit Compensation
Guides to help you understand and use this data
Nonprofit Executive Director Salary
What nonprofit executive directors earn, what drives the number, and how to use public compensation data whether you are a candidate, a current ED, or a board member.
Read moreHow to Look Up Nonprofit Salaries
Two approaches to finding executive compensation at any tax-exempt organization, from raw IRS filings to searchable databases.
Read moreAre Nonprofit Salaries Public?
What IRS Form 990 discloses about executive compensation, who has to report it, and how to look it up.
Read more